AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Intra-Cellular Therapies, Inc.
  3. Financials
  4. Return on Assets

Intra-Cellular Therapies, Inc.【ITCI】

Market cap
$13.4B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-7.1-62.15%
Dec 31, 2023-18.8-54.25%
Dec 31, 2022-41.2-12.51%
Dec 31, 2021-47.1+0.41%
Dec 31, 2020-46.9-3.46%
Dec 31, 2019-48.6+29.70%
Dec 31, 2018-37.4+64.72%
Dec 31, 2017-22.7-14.77%
Dec 31, 2016-26.7-21.72%
Dec 31, 2015-34.1-5.88%
Dec 31, 2014-36.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)